U.S. Acute Hospital Care Market (By Medical Condition: Emergency Care, Short-term Stabilization, Trauma Care, Acute Care Surgery, Others; By Facility Type: General Acute Care Hospitals, Psychiatric Hospitals, Specialized Hospitals, Rehabilitation Hospitals, Long-term Acute Care (LTAC); By Service: Intensive Care Unit (ICU), Neonatal Intensive Care Unit (NICU), Coronary Care Unit (CCU), Others) - U.S. Regional Outlook and Forecast 2024 to 2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Acute Hospital Care Market
5.1. COVID-19 Landscape: U.S. Acute Hospital Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Acute Hospital Care Market, By Medical Condition
8.1. U.S. Acute Hospital Care Market, by Medical Condition, 2024-2033
8.1.1 Emergency Care
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Short-term Stabilizatio
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Trauma Care
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Acute Care Surgery
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. U.S. Acute Hospital Care Market, By Facility Type
9.1. U.S. Acute Hospital Care Market, by Facility Type, 2024-2033
9.1.1. General Acute Care Hospitals
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Psychiatric Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Specialized Hospitals
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Rehabilitation Hospitals
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Long-term Acute Care (LTAC)
9.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 10. U.S. Acute Hospital Care Market, By Service
10.1. U.S. Acute Hospital Care Market, by Service, 2024-2033
10.1.1. Intensive Care Unit (ICU)
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Neonatal Intensive Care Unit (NICU)
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Coronary Care Unit (CCU)
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. U.S. Acute Hospital Care Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Medical Condition (2021-2033)
11.1.2. Market Revenue and Forecast, by Facility Type (2021-2033)
11.1.3. Market Revenue and Forecast, by Service (2021-2033)
Chapter 12. Company Profiles
12.1. TH Medical (Tenet Healthcare Corporation)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Universal Health Services Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Community Health Systems, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Ascension
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Lifepoint Health, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Ardent Health Services
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Emerus Hospital Partners, LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Emerus Hospital Partners, LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. NYU Langone Hospitals
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. NewYork-Presbyterian Hospital
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client